Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI (CONDI2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2013 by University of Aarhus
Sponsor:
Collaborators:
Rigshospitalet, Denmark
Aalborg Universityhospital
Odense University Hospital
Hospital Universitario Central de Asturias
Clinical Centre of Serbia
The Military Medical Academy, Belgrade, Serbia
The Hatter Cardiovascular Institute, London W, United Kingdom
Central Denmark Region
Prehospital Emergency Medical Service, The Region of Southern Denmark
Prehospital Emergency Medical Service, The North Denmark Region
Region Zealand
The Danish Medical Research Council
Information provided by (Responsible Party):
University of Aarhus ( Aarhus University Hospital )
ClinicalTrials.gov Identifier:
NCT01857414
First received: May 15, 2013
Last updated: May 15, 2014
Last verified: August 2013
  Purpose

The aim of the the study is to investigate whether Remote Ischaemic Conditioning (RIC) can improve clinical outcomes (cardiovascular death and hospitalisation for heart failure) at one year in patients presenting with ST-elevation Myocardial Infarction and undergoing primary percutaneous coronary intervention. This will be done in a multinational investigator-driven, multi-centre, randomised, controlled, single-blind, parallel assignment, prospective clinical efficacy trial.


Condition Intervention Phase
Myocardial Reperfusion Injury
Procedure: Remote Ischaemic Conditioning
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Multinational Multicentre Randomised Controlled Clinical Study

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Cardiovascular mortality [ Time Frame: One year ] [ Designated as safety issue: No ]
    Cardiovascular mortality and hospitalisation for heart failure at one year


Secondary Outcome Measures:
  • Myocardial infarct size [ Time Frame: 72 hours ] [ Designated as safety issue: No ]
    Myocardial infarct size at day 3 (72 hours area under curve serum troponin T)

  • Left ventricular function [ Time Frame: Three months ] [ Designated as safety issue: No ]
    Left ventricular function on day three and three months post pPCI (Echocardiography)

  • Prognosis [ Time Frame: One year ] [ Designated as safety issue: No ]
    Re-infarction, stroke and revascularisation at one year


Estimated Enrollment: 2300
Study Start Date: November 2013
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Remote Ischaemic Conditioning
Use of Remote Ischaemic Conditioning prior to primary percutaneous coronary intervention
Procedure: Remote Ischaemic Conditioning
The CellAegis auto RIC (automated blood pressure cuff) will be placed on the right upper arm and inflated to 200 mmHg for 5 minutes and then deflated for 5 minutes, a programmed cycle which is repeated 4 times in total (therefore the total length of the RIC protocol is 40 minutes). If the initial systolic blood pressure is >175 mmHg, the cuff will be inflated to 25 mmHg above the systolic blood pressure. In recruiting centres where randomisation occurs at the hospital or in cases with short transportation time, the RIC protocol will continue during PCI until successful or until immediately before reperfusion.
No Intervention: No use of Remote Ischaemic Conditioning
No use of Remote Ischaemic Conditioning prior to percutaneous coronary intervention

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female patients (>18 years old) presenting with chest pain for more than 30 minutes
  • Putative STEMI (ST-elevation at the J-point in two contiguous leads with the cut-off points: ≥0.2 millivolt (mV) in men or ≥0.15 mV in women in leads V2-V3 and/ or ≥0.1 mV in other leads)
  • New left bundle branch block who are eligible for pPCI (chest pain onset <12 hours) Informed consent obtained Life expectancy of more than 1 year

Exclusion Criteria:

  • Previous by-pass surgery
  • MI or treatment with thrombolysis within 30 days
  • Patients treated with cooling
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01857414

Contacts
Contact: Hans Erik Bøtker, Professor heb@dadlnet.dk
Contact: Kristine M Liendgaard, Adjunct kristine.moller@ki.au.dk

Locations
Denmark
The Heart Centre, Aalborg Sygehus Not yet recruiting
Aalborg, Denmark, 9100
Contact: Søren Hjortshøj, Consultant       sph@rn.dk   
Department of Cardiology, Aarhus University Hospital, Skejby Recruiting
Aarhus, Denmark, 8200
Contact: Hans Erik Bøtker, Professor       HEB@dadlnet.dk   
Contact: Kristine M Liendgaard, Adjunct       kristine.moller@ki.au.dk   
The Heart Centre, Rigshospitalet, Copenhagen University Not yet recruiting
Copenhagen, Denmark, 2100
Contact: Thomas Engstrøm, Consultant       Thomas.engstroem@rh.regionh.dk   
Department of Cardiology, Odense University Hospital Not yet recruiting
Odense, Denmark, 5000
Contact: Lissette O Jensen, Lecturer       okkels@dadlnet.dk   
Serbia
The Clinical Center of Serbia Not yet recruiting
Belgrade, Serbia, 11000
Contact: Dejan Milasinovic, Professor       d.mil8412@gmail.com   
Contact: Goran Stankovic, Professor       gorastan@sbb.rs   
Military Medical Academy, Belgrade Not yet recruiting
Belgrade, Serbia, 11000
Contact: Slobodan Obradovic, Professor       sloba.d.obradovic@gmail.com   
Spain
Hospital Universitario Central de Asturias Not yet recruiting
Oviedo, Spain, 33006
Contact: José MG Ruiz, Group leader       josemanuel.garcia@externo.cnic.es   
United Kingdom
The Hatter Cardiovascular Institute, University College London Not yet recruiting
London, United Kingdom, WC1E 6HX
Contact: Derek Hausenloy, Scientist       d.hausenloy@ucl.ac.uk   
Sponsors and Collaborators
Aarhus University Hospital
Rigshospitalet, Denmark
Aalborg Universityhospital
Odense University Hospital
Hospital Universitario Central de Asturias
Clinical Centre of Serbia
The Military Medical Academy, Belgrade, Serbia
The Hatter Cardiovascular Institute, London W, United Kingdom
Central Denmark Region
Prehospital Emergency Medical Service, The Region of Southern Denmark
Prehospital Emergency Medical Service, The North Denmark Region
Region Zealand
The Danish Medical Research Council
Investigators
Principal Investigator: Hans Erik Bøtker, Professor Aarhus University Hospital
  More Information

No publications provided

Responsible Party: University of Aarhus ( Aarhus University Hospital )
ClinicalTrials.gov Identifier: NCT01857414     History of Changes
Other Study ID Numbers: Condi2-37747
Study First Received: May 15, 2013
Last Updated: May 15, 2014
Health Authority: Denmark: Ethics Committee
Denmark: Danish Dataprotection Agency

Keywords provided by University of Aarhus:
ST-elevation myocardial infarction
Remote Ischaemic Conditioning
Myocardial Reperfusion Injury
Cardiovascular mortality

Additional relevant MeSH terms:
Myocardial Infarction
Myocardial Reperfusion Injury
Reperfusion Injury
Wounds and Injuries
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Cardiomyopathies
Postoperative Complications
Pathologic Processes

ClinicalTrials.gov processed this record on July 22, 2014